Search Legislation

The Health Service Products (Provision and Disclosure of Information) Regulations 2018

What Version

 Help about what version
  • Latest available (Revised)
  • Original (As made)

Status:

This is the original version (as it was originally made). This item of legislation is currently only available in its original format.

PART 2Quarterly information about unbranded generic health service medicines

Meaning of “unbranded generic health service medicine” and listing of a presentation of unbranded generic health service medicine

6.—(1) In these Regulations, “unbranded generic health service medicine” means a health service medicine(1) the labelling of which includes the common name of the product, but does not include an invented name.

(2) For the purposes of paragraph (1)—

“invented name” means a name which—

(a)

is not the common name of the medicinal product, and

(b)

is not liable to be confused with that name;

“non-proprietary name” means a name which is, or is a permitted variation of—

(a)

an International Non-proprietary Name (INN),

(b)

an International Non-proprietary Name Modified (INNM),

(c)

a British Approved Name (BAN),

(d)

a British Approved Name Modified (BANM), or

(e)

an approved name.

(3) The names mentioned in paragraphs (a) to (e) of the definition of “non-proprietary name” (and their permitted variations) have the same meanings as in a list of names which has been prepared and published under regulation 318 of the 2012 Regulations and which is in force(2).

(4) For the purposes of this Part, a presentation of unbranded generic health service medicine is listed in a Drug Tariff if a price for that presentation is listed—

(a)in the Drug Tariff (England)(3) for the given month,

(b)in the Drug Tariff (Wales)(4) for the given month,

(c)in the Drug Tariff (Scotland)(5) for the given month, or

(d)in the Drug Tariff (Northern Ireland)(6) for the given month.

(5) For the purposes of determining whether a reimbursement price is listed for a presentation, any pack size specified in the relevant Drug Tariff is to be disregarded.

Information to be recorded and kept about supply of unbranded generic health service medicines: manufacturers and importers

7.—(1) A relevant producer must record the information mentioned in paragraph (3) for each presentation of unbranded generic health service medicine which—

(a)the producer manufactures, or imports, and supplies to any of the following—

(i)a UK primary medical services provider,

(ii)a Health Service chemist, or

(iii)a medicines wholesaler,

(b)is, in the month in which the producer supplies it, listed in a Drug Tariff, and

(c)if it is a liquid or a topical preparation, or is in tablet or capsule form, is in a pack not exceeding the maximum pack size.

(2) The relevant producer must keep the information recorded under paragraph (1) until it is provided to the Secretary of State in accordance with regulation 9.

(3) The information is—

(a)the number of packs supplied to persons mentioned in paragraph (1)(a)(i) to (iii), and

(b)the net sales income, or a reasonable estimate of the net sales income, from that supply.

(4) In this regulation, “relevant producer” means—

(a)a manufacturer(7), or

(b)a UK producer who is an importer.

Information to be recorded and kept about supply of unbranded generic health service medicines: medicines wholesalers

8.—(1) A UK producer who is a medicines wholesaler must—

(a)record the information mentioned in paragraph (2) for each presentation of unbranded generic health service medicine which the producer purchases for supply (including any purchase which requires the presentation to be imported into the United Kingdom) and—

(i)which is, in the month in which producer purchases it, listed in a Drug Tariff, and

(ii)if it is a liquid or a topical preparation, or is in tablet or capsule form, which is in a pack not exceeding the maximum pack size, and

(b)keep that information until it is provided to the Secretary of State in accordance with regulation 9.

(2) The information is—

(a)the number of packs purchased, and

(b)the net purchase amount, or a reasonable estimate of the net purchase amount, for that purchase.

(3) A UK producer who is a medicines wholesaler must also—

(a)record the information mentioned in paragraph (4) for each presentation of unbranded generic health service medicine (other than a presentation which the wholesaler has manufactured) which—

(i)the producer supplies to any UK primary medical services provider or Health Service chemist,

(ii)is, in the month in which the producer supplies it, listed in a Drug Tariff, and

(iii)if it is a liquid or a topical preparation, or is in tablet or capsule form, is in a pack which does not exceed the maximum pack size, and

(b)keep that information until it is provided to the Secretary of State in accordance with regulation 9.

(4) The information is—

(a)the number of packs supplied to persons mentioned in paragraph (3)(a)(i), and

(b)the net sales income, or a reasonable estimate of the net sales income, from that supply.

Requirement to provide information about supply of unbranded generic health service medicines

9.—(1) A UK producer must provide the information which the producer is required to record and keep under regulation 7 or 8 to the Secretary of State in accordance with this regulation.

(2) The information must be provided, in each year, for the following quarterly periods—

(a)1st July to 30th September;

(b)1st October to 31st December;

(c)1st January to 31st March;

(d)1st April to 30th June.

(3) The information for a quarterly period must be provided—

(a)in an electronic spreadsheet provided for that purpose by the Secretary of State, or

(b)if the Secretary of State does not provide such a spreadsheet, via the NHS Digital online gateway.

(4) The information for a quarterly period must be provided within the period of 28 days beginning with the first day of the month which begins immediately after the end of that quarterly period.

(1)

See section 266(6) of the National Health Service Act 2006 for the definition of “health service medicine”.

(2)

Copies of the list can be obtained from: https://www.pharmacopoeia.com/what-is-the-ban-book or The Stationery Office, PO Box 29, Norwich, NR3 1GN.

(3)

The Drug Tariff (England) is available at https://www.nhsbsa.nhs.uk/pharmacies-gp-practices-and-appliance-contractors/drug-tariff or from NHS Business Services Authority, Stella House, Goldcrest Way, Newburn Riverside, Newcastle upon Tyne, NEI5 8NY.

(4)

The Drug Tariff (Wales) is available at https://www.nhsbsa.nhs.uk/pharmacies-gp-practices-and-appliance-contractors/drug-tariff or from NHS Business Services Authority, Stella House, Goldcrest Way, Newburn Riverside, Newcastle upon Tyne, NEI5 8NY.

(5)

The Drug Tariff (Scotland) is available at http://www.isdscotland.org/Health-Topics/Prescribing-and-Medicines/Scottish-Drug-Tariff/ or from Information Services Division, NHS National Services Scotland, Gyle Square, 1 South Gyle Crescent, Edinburgh EH12 9EB.

(6)

The Drug Tariff (Northern Ireland) is available at http://www.hscbusiness.hscni.net/services/2034.htm or from Business Services Organisation Headquarters, 2 Franklin Street Belfast, BT2 8DQ.

(7)

See section 266(6) of the National Health Service Act 2006 (c. 41) for the definition of “manufacturer”.

Back to top

Options/Help

Print Options

Close

Legislation is available in different versions:

Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.

Original (As Enacted or Made):The original version of the legislation as it stood when it was enacted or made. No changes have been applied to the text.

Close

Opening Options

Different options to open legislation in order to view more content on screen at once

Close

Explanatory Memorandum

Explanatory Memorandum sets out a brief statement of the purpose of a Statutory Instrument and provides information about its policy objective and policy implications. They aim to make the Statutory Instrument accessible to readers who are not legally qualified and accompany any Statutory Instrument or Draft Statutory Instrument laid before Parliament from June 2004 onwards.

Close

More Resources

Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:

  • the original print PDF of the as enacted version that was used for the print copy
  • lists of changes made by and/or affecting this legislation item
  • confers power and blanket amendment details
  • all formats of all associated documents
  • correction slips
  • links to related legislation and further information resources
Close

Impact Assessments

Impact Assessments generally accompany all UK Government interventions of a regulatory nature that affect the private sector, civil society organisations and public services. They apply regardless of whether the regulation originates from a domestic or international source and can accompany primary (Acts etc) and secondary legislation (SIs). An Impact Assessment allows those with an interest in the policy area to understand:

  • Why the government is proposing to intervene;
  • The main options the government is considering, and which one is preferred;
  • How and to what extent new policies may impact on them; and,
  • The estimated costs and benefits of proposed measures.
Close

More Resources

Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:

  • the original print PDF of the as made version that was used for the print copy
  • correction slips

Click 'View More' or select 'More Resources' tab for additional information including:

  • lists of changes made by and/or affecting this legislation item
  • confers power and blanket amendment details
  • all formats of all associated documents
  • links to related legislation and further information resources